Today Utah Medical Products, Inc. (UTMD) Stock Reaches 52-Week High

March 21, 2018 - By Louis Casey

Investors sentiment increased to 1.57 in 2017 Q3. Its up 0.19, from 1.38 in 2017Q2. It is positive, as 3 investors sold Utah Medical Products, Inc. shares while 20 reduced holdings. 6 funds opened positions while 30 raised stakes. 2.41 million shares or 0.13% more from 2.40 million shares in 2017Q2 were reported.
Hancock Hldgs holds 0.01% in Utah Medical Products, Inc. (NASDAQ:UTMD) or 2,850 shares. Rhumbline Advisers reported 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). The California-based Schwab Charles Investment Mngmt has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Financial Bank Of America De holds 0% of its portfolio in Utah Medical Products, Inc. (NASDAQ:UTMD) for 241 shares. Clean Yield Group Incorporated holds 1.44% of its portfolio in Utah Medical Products, Inc. (NASDAQ:UTMD) for 48,149 shares. California Employees Retirement Sys owns 16,950 shares or 0% of their US portfolio. 4,900 are held by Wedge Cap Mgmt L Ltd Partnership Nc. Oppenheimer Asset Management holds 0% or 907 shares in its portfolio. 17,093 are held by Morgan Stanley. Millennium Management Ltd Liability Co holds 10,517 shares or 0% of its portfolio. Us Bancorporation De reported 12,194 shares. Century owns 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 67,094 shares. Advisory Ser Ntwk Lc reported 3,540 shares. Legal & General Gru Plc holds 1,031 shares or 0% of its portfolio. First Quadrant Limited Partnership Ca invested 0.01% of its portfolio in Utah Medical Products, Inc. (NASDAQ:UTMD).

Since February 2, 2018, it had 0 buys, and 8 insider sales for $1.56 million activity. The insider PAYNE BARBARA A sold $90,700. HOYER ERNST G sold $134,673 worth of stock.

The stock of Utah Medical Products, Inc. (NASDAQ:UTMD) hit a new 52-week high and has $102.50 target or 6.00 % above today’s $96.70 share price. The 6 months bullish chart indicates low risk for the $360.28M company. The 1-year high was reported on Mar, 21 by If the $102.50 price target is reached, the company will be worth $21.62M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 1.84% or $1.75 during the last trading session, reaching $96.7. About 13,053 shares traded. Utah Medical Products, Inc. (NASDAQ:UTMD) has declined 0.94% since March 21, 2017 and is downtrending. It has underperformed by 17.64% the S&P500.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $360.28 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 42.49 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: